GlassScriptPhysician profile
William Earl Porter
NPI 1336156165
$2,312.52
in general payments reported to CMS, 2019-2025
37 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $416 · 2021: $320 · 2022: $334 · 2023: $206 · 2024: $562 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,053.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $268.93 | 2019-2024 | Rybelsus, Ozempic |
| Lilly USA, LLC | $190.38 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $157.49 | 2020-2022 | |
| Edwards Lifesciences Corporation | $144.53 | 2025 | Sapien 3 Ultra Resilia |
| Insulet Corporation | $139.27 | 2023-2024 | Omnipod |
| Merck Sharp & Dohme LLC | $135.35 | 2019-2025 | Capvaxive, Gardasil 9 |
| Inspire Medical Systems, INC. | $121.40 | 2024-2025 | Inspire |
| Pfizer INC. | $118.75 | 2019-2022 | |
| Medtronic, INC. | $90.06 | 2024-2025 | Intellis Adaptivestim, Minimed 780g |
| Abbott Laboratories | $80.72 | 2023-2024 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $75.42 | 2019-2021 | |
| Amarin Pharma, INC. | $72.70 | 2020-2021 | |
| Tandem Diabetes Care, INC. | $65.18 | 2023-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Corcept Therapeutics | $62.75 | 2023-2024 | Korlym |
| Xeris Pharmaceuticals, INC. | $58.50 | 2022-2024 | Gvoke Hypopen, Recorlev |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.